Press Releases

 
Press Releases
  Date Title and Summary View
Oct 14, 2016
SAN DIEGO, Oct. 14, 2016 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to provide information to physicians to improve the diagnosis and treatment of cancer, announces the pricing of an underwritten public offering of 9,100,000 shares of its common stock and ...
Sep 29, 2016
In the news release, Clinical Results Demonstrating the Performance of Biocept's Target Selector Platform to be Presented at the 2016 European Society of Medical Oncology Annual Congress, issued 29-Sep-2016 by Biocept, Inc. over PR Newswire, we are advised by the company that the first paragraph, last sentence, should have the hyperlink https://csl...
Sep 29, 2016
SAN DIEGO, Sept. 29, 2016 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to provide information to physicians to improve the diagnosis and treatment of cancer, announces that clinical results featuring its liquid biopsy platform will be presented at the 2016 E...
Sep 23, 2016
SAN DIEGO, Sept. 23, 2016 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to provide information to physicians to improve the diagnosis and treatment of cancer, announces that Lyle Arnold, Ph.D., Chief Scientific Officer of Biocept, will present at two SelectBi...
Sep 13, 2016
SAN DIEGO, Sept. 9, 2016 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to provide information to physicians to improve the diagnosis and treatment of cancer, announces a research collaboration with Shilpa Gupta, Ph.D., Assistant Professor in the Hematology On...
Sep 1, 2016
SAN DIEGO, Sept. 1, 2016 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to provide information to physicians to improve the diagnosis and treatment of cancer, announces the grant of a Chinese patent entitled, METHODS AND REAGENTS FOR SIGNAL AMPLIFICATION.  The...
Aug 30, 2016
SAN DIEGO, Aug. 30, 2016 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to provide information to physicians to improve the diagnosis and treatment of cancer, announces a preferred provider agreement with Teneovita Medical, a division of Teneovita Medical Inno...
Aug 18, 2016
SAN DIEGO, Aug. 18, 2016 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing biomarkers to improve the detection and treatment of cancer, announces that Veena Singh, M.D., Senior Vice President and Senior Medical Director of Biocept, will present "Liquid Biopsy: Providing Answers that Matter" on August 25, ...
Aug 11, 2016
SAN DIEGO, Aug. 11, 2016 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to provide information to physicians to improve the diagnosis and treatment of cancer, announces a preferred provider agreement with HarlePhil Ventures, Inc., a wholly owned subsidiary of ...
Aug 2, 2016
SAN DIEGO, Aug. 2, 2016 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to provide information to physicians to improve the diagnosis and treatment of cancer, reports financial results for the three and six months ended June 30, 2016, and provides an update on ...
Page: FirstPrevious
3
... NextLast
= add release to Briefcase